Nuvalent shares surged 38.9% in premarket trading. GSK has agreed to buy U.S.-listed cancer drug developer Nuvalent for $10.6 billion in its largest deal in years, marking a strategic shift under new CEO Luke Miels as the drugmaker steps up its focus on oncology. The all-cash deal values Nuvalent at approximately $124 per share, a 40% premium to its last closing price.
Applied Digital jumped 10.2% in premarket trading. The move followed a 15-year Delta Forge 2 lease projected to generate about $5.2 billion.
Chip stocks rallied again in premarket trading. Micron, Qualcomm, Marvell Technology, SanDisk, and Arm rose 3%; Western Digital, Seagate, Cerebras Systems, and Intel rose 2%.
Space stocks gained in premarket trading. Momentus rose 6%; BlackSky rose 5%; Firefly Aerospace, Rocket Lab, Intuitive Machines, and AST SpaceMobile rose 3%.
Optical communication stocks also rose in premarket trading. Applied Optoelectronics rose 4%; AXT, Corning, Coherent, POET Technologies, and Credo Technology rose 3%; Lumentum and Semtech rose 2%.
Comments